Work

Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Current Medical Research and Opinion

DOI: 10.1185/03007991003672551

Authors: Y. Seino, M.F. Rasmussen, T. Nishida, K. Kaku

Institutions: Kansai Electric Power (Japan), Kansai Electric Power Hospital, Novo Nordisk (Denmark), Novo Nordisk Pharma Ltd. (Japan), Kawasaki Medical School

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk

OpenAlex ID: W2012425163

FWCI: 9.32

Cites: 18

Cited by: 118

Related to: 10